Timothy S Ernst sold $826k of BIO
EVP, General Counsel & Sec at BIO-RAD LABORATORIES, INC.. 2,500 shares at an average of $330.55, traded Feb 28, 2024, filed Feb 29, 2024.
Score components
- +15RoleOfficer
- +23Trade size$826k at market
- +10Share of holdings soldSold 42% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +6.1%, 3m -13.5%, 6m +2.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-24-004959, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 28, 2024 | MOption exercise Bio-Rad A Common Stock | +2,500 | $326.15 | $815k | 5,897 | Feb 29, 2024 |
| Feb 28, 2024 | SOpen-market sale Bio-Rad A Common Stock | -2,500 | $330.55 | $826k | 3,397 | Feb 29, 2024 |
| Feb 28, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -2,500 | $0.00 | $0 | 0 | Feb 29, 2024 |
Related signals
Other insiders at BIO-RAD LABORATORIES, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | BIOsell BIO-RAD LABORATORIES, INC. | Eva Anette Engelhardt EVP, President, CDG | $136k 550 shares | -61% | |
| 47Moderate | BIOsell BIO-RAD LABORATORIES, INC. | James Barry EVP, President, LSG | $214k 700 shares | -58% | |
| 31Weak | BIOsell BIO-RAD LABORATORIES, INC. | Michael Crowley EVP, GBL Commercial Operations | $741k 3,000 shares | -27% | |
| 48Moderate | BIO-RAD LABORATORIES, INC. | Andrew J. Last EVP, Chief Operating Officer | $990k 3,000 shares | -28% | |
| 40Moderate | BIO-RAD LABORATORIES, INC. | James Barry EVP, President, LSG | $206k 623 shares | -81% | |
| 25Weak | BIOsell BIO-RAD LABORATORIES, INC. | Michael Crowley EVP, GBL Commercial Operations | $104k 369 shares | -5% | |
| 28Weak | BIOsell BIO-RAD LABORATORIES, INC. | Steven D Schwartz owner | $148k 320 shares | -18% | |
| 43Moderate | BIO-RAD LABORATORIES, INC. | Michael Crowley EVP, GBL Commercial Operations | $1.0M 3,000 shares | -30% | |
| 48Moderate | BIO-RAD LABORATORIES, INC. | Dara Wright EVP, President, CDG | $359k 1,200 shares | -44% | |
| 35Weak | BIO-RAD LABORATORIES, INC. | Michael Crowley EVP, GBL Commercial Operations | $196k 642 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.